APA (7th ed.) Citation

LF, v. D., N, B., JC, H., SR, V., J, K., MP, L., . . . MP, L. (2017). Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions. Molecular oncology, 11(3), 295. https://doi.org/10.1002/1878-0261.12037

Chicago Style (17th ed.) Citation

LF, van Dessel, et al. "Application of Circulating Tumor DNA in Prospective Clinical Oncology Trials - Standardization of Preanalytical Conditions." Molecular Oncology 11, no. 3 (2017): 295. https://doi.org/10.1002/1878-0261.12037.

MLA (9th ed.) Citation

LF, van Dessel, et al. "Application of Circulating Tumor DNA in Prospective Clinical Oncology Trials - Standardization of Preanalytical Conditions." Molecular Oncology, vol. 11, no. 3, 2017, p. 295, https://doi.org/10.1002/1878-0261.12037.